119 related articles for article (PubMed ID: 35034028)
1. Bone Infarct-Associated Osteosarcoma: Epidemiologic and Survival Trends.
Laranga R; Focaccia M; Evangelista A; Lucarelli E; Donati DM; Spazzoli B
Oncol Res Treat; 2022; 45(6):326-335. PubMed ID: 35034028
[TBL] [Abstract][Full Text] [Related]
2. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
Lee RJ; Arshi A; Schwartz HC; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
[TBL] [Abstract][Full Text] [Related]
4. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
5. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
[TBL] [Abstract][Full Text] [Related]
6. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma.
Aung L; Gorlick R; Healey JH; Shi W; Thaler HT; Shorter NA; Huvos AG; Meyers PA
J Clin Oncol; 2003 Jan; 21(2):342-8. PubMed ID: 12525528
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
[TBL] [Abstract][Full Text] [Related]
8. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma in patients older than 65 years.
Longhi A; Errani C; Gonzales-Arabio D; Ferrari C; Mercuri M
J Clin Oncol; 2008 Nov; 26(33):5368-73. PubMed ID: 18809616
[TBL] [Abstract][Full Text] [Related]
10. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
[TBL] [Abstract][Full Text] [Related]
11. Risk-Based Therapy for Localized Osteosarcoma.
Venkatramani R; Murray J; Helman L; Meyer W; Hicks MJ; Krance R; Lau C; Jo E; Chintagumpala M
Pediatr Blood Cancer; 2016 Mar; 63(3):412-7. PubMed ID: 26501936
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
13. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
[TBL] [Abstract][Full Text] [Related]
14. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of elderly patients with osteosarcoma.
Imura Y; Takenaka S; Kakunaga S; Nakai T; Wakamatsu T; Outani H; Tanaka T; Tamiya H; Oshima K; Hamada K; Naka N; Araki N; Kudawara I; Ueda T; Yoshikawa H
Int Orthop; 2019 Jul; 43(7):1741-1747. PubMed ID: 31011764
[TBL] [Abstract][Full Text] [Related]
17. What has changed in the last 25 years in osteosarcoma treatment? A single center experience.
Ataseven E; Göktepe ŞÖ; Kaya H; Tamsel İ; Keçeci B; Argın M; Doğanavşargil B; Sabah D; Burak Z; Kantar M
Turk J Pediatr; 2023; 65(1):54-63. PubMed ID: 36866985
[TBL] [Abstract][Full Text] [Related]
18. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.
Isakoff MS; Barkauskas DA; Ebb D; Morris C; Letson GD
Clin Orthop Relat Res; 2012 Jul; 470(7):2007-13. PubMed ID: 22354612
[TBL] [Abstract][Full Text] [Related]
19. Diagnoses, treatment, and oncologic outcomes in patients with calcaneal malignances: Case series, systematic literature review, and pooled cohort analysis.
Newman ET; van Rein EAJ; Theyskens N; Ferrone ML; Ready JE; Raskin KA; Lozano Calderon SA
J Surg Oncol; 2020 Dec; 122(8):1731-1746. PubMed ID: 32974945
[TBL] [Abstract][Full Text] [Related]
20. EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Ferrari S; Bielack SS; Smeland S; Longhi A; Egerer G; Sundby Hall K; Donati D; Kevric M; Brosjö O; Comandone A; Werner M; Monge O; Palmerini E; Berdel WE; Bjerkehagen B; Paioli A; Lorenzen S; Eriksson M; Gambarotti M; Tunn PU; Jebsen NL; Cesari M; von Kalle T; Ferraresi V; Schwarz R; Bertulli R; Kasparek AK; Grignani G; Krasniqi F; Sorg B; Hecker-Nolting S; Picci P; Reichardt P
Tumori; 2018; 104(1):30-36. PubMed ID: 29218692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
